| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JNR.20962 |
| P698 | PubMed publication ID | 16773650 |
| P50 | author | Michael Chopp | Q71037672 |
| P2093 | author name string | Yi Li | |
| Jing Zhang | |||
| Jieli Chen | |||
| Mei Lu | |||
| Yisheng Cui | |||
| Stanton B Elias | |||
| Lori Noffsinger | |||
| P2860 | cites work | Expression of neurotrophins and their receptors in human bone marrow | Q24669854 |
| Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats | Q28209989 | ||
| Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery | Q44115092 | ||
| P433 | issue | 3 | |
| P921 | main subject | experimental autoimmune encephalomyelitis | Q494066 |
| bone marrow | Q546523 | ||
| P304 | page(s) | 587-595 | |
| P577 | publication date | 2006-08-01 | |
| P1433 | published in | Journal of Neuroscience Research | Q6295654 |
| P1476 | title | Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice | |
| P478 | volume | 84 |
| Q42735915 | Adult human mesenchymal cells proliferate and migrate in response to chemokines expressed in demyelination |
| Q35665164 | Aire controls mesenchymal stem cell-mediated suppression in chronic colitis |
| Q36443654 | Autologous mesenchymal stem cells applied on the pressure ulcers had produced a surprising outcome in a severe case of neuromyelitis optica |
| Q35757641 | Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study |
| Q54565698 | Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts. |
| Q37218139 | Bone marrow stromal cell therapy reduces proNGF and p75 expression in mice with experimental autoimmune encephalomyelitis |
| Q36994879 | Bone marrow stromal cells protect oligodendrocytes from oxygen-glucose deprivation injury |
| Q84597977 | Bone marrow stromal cells-loaded chitosan conduits promote repair of complete transection injury in rat spinal cord |
| Q47619959 | Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases |
| Q47885870 | Cell-based therapeutic strategies for multiple sclerosis |
| Q30437823 | Clinical applications of mesenchymal stem cells in chronic diseases |
| Q33761185 | Comparison of bone marrow stromal cells derived from stroke and normal rats for stroke treatment. |
| Q39356461 | Concise Review: Mesenchymal Stem Cells in Neurodegenerative Diseases |
| Q38088965 | Concise review: adult mesenchymal stem cells, adult neural crest stem cells, and therapy of neurological pathologies: a state of play |
| Q28396387 | Conditioned medium of human adipose-derived mesenchymal stem cells mediates protection in neurons following glutamate excitotoxicity by regulating energy metabolism and GAP-43 expression |
| Q35788582 | Disparate Effects of Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis and Cuprizone-Induced Demyelination. |
| Q48100073 | Dynamic Changes in Brain Mesenchymal Perivascular Cells Associate with Multiple Sclerosis Disease Duration, Active Inflammation, and Demyelination. |
| Q36187725 | Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination |
| Q37372173 | Effective combination of human bone marrow mesenchymal stem cells and minocycline in experimental autoimmune encephalomyelitis mice |
| Q36492135 | Evaluation of corticospinal axon loss by fluorescent dye tracing in mice with experimental autoimmune encephalomyelitis |
| Q34481082 | Exosomes/miRNAs as mediating cell-based therapy of stroke |
| Q34114518 | Fusion between human mesenchymal stem cells and rodent cerebellar Purkinje cells |
| Q93136005 | Human ES-derived MSCs correct TNF-α-mediated alterations in a blood-brain barrier model |
| Q48191794 | Human Umbilical Cord Mesenchymal Stem Cells Protect Against SCA3 by Modulating the Level of 70 kD Heat Shock Protein. |
| Q43195511 | Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration |
| Q43578851 | Human mesenchymal stem cells infiltrate the spinal cord, reduce demyelination, and localize to white matter lesions in experimental autoimmune encephalomyelitis. |
| Q37926524 | Immunosuppressive properties of mesenchymal stem cells |
| Q39930711 | Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosis |
| Q46914450 | Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's disease. |
| Q38957213 | Intraventricular injections of mesenchymal stem cells activate endogenous functional remyelination in a chronic demyelinating murine model. |
| Q37781509 | MSCs: Biological characteristics, clinical applications and their outstanding concerns |
| Q41486306 | Mechanisms of oxidative damage in multiple sclerosis and a cell therapy approach to treatment. |
| Q57658201 | Mesenchymal Stem Cells Shape Microglia Effector Functions Through the Release of CX3CL1 |
| Q38080971 | Mesenchymal autologous stem cells |
| Q37975162 | Mesenchymal cell populations: development of the induction systems for Schwann cells and neuronal cells and finding the unique stem cell population |
| Q38057682 | Mesenchymal stem cells as treatment for MS - progress to date. |
| Q37891375 | Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases |
| Q35422678 | Mesenchymal stem cells in multiple sclerosis - translation to clinical trials |
| Q41790153 | Mesenchymal stromal-cell transplants induce oligodendrocyte progenitor migration and remyelination in a chronic demyelination model. |
| Q55008316 | MicroRNA Let-7f-5p Promotes Bone Marrow Mesenchymal Stem Cells Survival by Targeting Caspase-3 in Alzheimer Disease Model. |
| Q46362410 | Paracrine Mechanisms of Mesenchymal Stem Cells in Tissue Repair |
| Q49961729 | Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis. |
| Q37194115 | Potential clinical applications of adult human mesenchymal stem cell (Prochymal®) therapy |
| Q37218580 | Protecting axons in multiple sclerosis |
| Q53239757 | Protective effects of matrine on experimental autoimmune encephalomyelitis via regulation of ProNGF and NGF signaling. |
| Q36700629 | Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis |
| Q47586113 | Safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis. |
| Q34564111 | Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis |
| Q35654828 | Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury. |
| Q91761207 | Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis-A Phase I Study |
| Q37991400 | Stem cell therapy for multiple sclerosis: preclinical evidence beyond all doubt? |
| Q38341972 | Stem cells for amyotrophic lateral sclerosis modeling and therapy: myth or fact? |
| Q37747349 | Stem cells in genetic myelin disorders |
| Q37519562 | Systemic neurotransplantation--a problem-oriented systematic review |
| Q33346315 | TSP-1 secreted by bone marrow stromal cells contributes to retinal ganglion cell neurite outgrowth and survival |
| Q26823691 | The immunomodulatory and neuroprotective effects of mesenchymal stem cells (MSCs) in experimental autoimmune encephalomyelitis (EAE): a model of multiple sclerosis (MS) |
| Q33577019 | The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis |
| Q37982954 | The remyelination Philosopher's Stone: stem and progenitor cell therapies for multiple sclerosis. |
| Q33771698 | The stem cell secretome and its role in brain repair |
| Q37978701 | The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms |
| Q37677911 | The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group |
| Q36737833 | Therapeutic potential of mesenchymal stem cells in regenerative medicine |
| Q38098448 | Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system |
| Q54988530 | Transcriptional Profiling of Mesenchymal Stem Cells Identifies Distinct Neuroimmune Pathways Altered by CNS Disease. |
Search more.